Skip to contentBIENAIME JEAN JACQUES — BIOMARIN PHARMACEUTICAL INC insider: 1,652 transactions · InsiderLensBIENAIME JEAN JACQUES
- Director at BIOMARIN PHARMACEUTICAL INC · on record since Jan 4, 2006
- Director at INSITUFORM TECHNOLOGIES INC · on record since Mar 31, 2004
- Director at NeurogesX Inc · on record since Jun 29, 2007
- Director at Ascendis Pharma A/S · on record since Apr 1, 2026
- Director at GENENCOR INTERNATIONAL INC · on record since Aug 29, 2003
- Director at SANGSTAT MEDICAL CORP · on record since Sep 8, 2003
- Director at Keros Therapeutics, Inc. · on record since Apr 17, 2026
- Director at INTERMUNE INC · on record since Mar 28, 2012
- Director at PORTOLA PHARMACEUTICALS INC · on record since May 30, 2013
- Chief Executive Officer at BIOMARIN PHARMACEUTICAL INC · on record since May 23, 2013
- Director at Immunome Inc. · on record since May 19, 2026
- Director at INCYTE CORP · on record since May 28, 2026
- Director at IMMUNIC, INC. · on record since Apr 23, 2014
- Chairman, President and CEO at GENENCOR INTERNATIONAL INC · on record since Dec 13, 2004
Insider trading activity of BIENAIME JEAN JACQUES
- Transactions on record
- 1,652
- since Aug 29, 2003
- Open-market buys
- 113
- $2.2M
- Open-market sells
- 555
- $243.3M
- Companies traded
- 12
- last filing Jun 17, 2026
Figures computed from official regulatory filings — methodology.
Companies where BIENAIME JEAN JACQUES has traded
- Keros Therapeutics, Inc.9 tx · $44.7K · Jun 17, 2026
- Immunome Inc.17 tx · $845K · Jun 12, 2026
- INCYTE CORP58 tx · $3.6M · Jun 10, 2026
- Ascendis Pharma A/S5 tx · $206.7K · Jun 1, 2026
- BIOMARIN PHARMACEUTICAL INC1392 tx · $391.6M · May 21, 2024
- IMMUNIC, INC.16 tx · $323.5K · Sep 24, 2018
- INTERMUNE INC19 tx · $744.9K · Oct 1, 2014
- PORTOLA PHARMACEUTICALS INC6 tx · $76.2K · May 19, 2014
- NeurogesX Inc77 tx · $264.6K · Feb 9, 2012
Track record of BIENAIME JEAN JACQUES
Statistical track record
Free- Open-market buys
- 113
- Last buy
- Jun 15, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BIENAIME JEAN JACQUES
Co-insiders of BIENAIME JEAN JACQUES
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
7 tx · Apr 22, 2005
DRAPEAU LOUISBIOMARIN PHARMACEUTICAL INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 17, 2026 | Buy | 1,000 | 10.19 USD | — | SEC |
| Jun 12, 2026 | AwardD | 9,897 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | Award | 1,642 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | AwardD | 6,111 | 0.00 USD | $0 | SEC |
| Jun 9, 2026 | Sell | -10,000 | 19.41 USD | $194.1K | SEC |
| Jun 9, 2026 | Buy | 1,000 | 19.27 USD | $19.3K | SEC |
| Jun 9, 2026 | Buy | 3,500 | 19.46 USD | $68.1K | SEC |
| Jun 9, 2026 | Buy | 6,000 | 19.48 USD | $116.9K | SEC |
| Jun 9, 2026 | Sell | -500 | 19.44 USD | $9.7K | SEC |
| Jun 5, 2026 | AwardD | 7,433 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | Award | 7,142 | 0.00 USD | $0 | SEC |
| Jun 1, 2026 | Buy | 200 | 222.30 USD | $44.5K | SEC |
| Jun 1, 2026 | Buy | 100 | 223.50 USD | $22.4K | SEC |
| Jun 1, 2026 | Buy | 200 | 223.76 USD | $44.8K | SEC |
| May 28, 2026 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| May 28, 2026 | Exercise | 15,000 | 84.53 USD | $1.3M | SEC |
| May 28, 2026 | Other | -13,059 | 97.10 USD | $1.3M | SEC |
| May 27, 2026 | Buy | 200 | 236.24 USD | $47.2K | SEC |
| May 27, 2026 | Buy | 200 | 239.37 USD | $47.9K | SEC |
| May 19, 2026 | Buy | 5,000 | 20.70 USD | $103.5K | SEC |
| May 19, 2026 | Buy | 1,000 | 10.58 USD | $10.6K | SEC |
| Apr 17, 2026 | Buy | 1,000 | 11.70 USD | $11.7K | SEC |
| Mar 12, 2026 | Buy | 1,000 | 21.55 USD | $21.6K | SEC |
| Mar 12, 2026 | Buy | 1,000 | 22.12 USD | $22.1K | SEC |
| Mar 11, 2026 | Buy | 2,000 | 11.21 USD | $22.4K | SEC |